Kcnma1 Protein (Bk Channel) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Protein Name | Calcium-Activated Potassium Channel Subunit Alpha-1 |
|---|
| Gene | KCNMA1 |
|---|
| UniProt ID | Q12703 |
|---|
| PDB Structure | 6V33, 5A6E |
|---|
| Molecular Weight | ~125 kDa |
|---|
| Subcellular Localization | Plasma Membrane |
|---|
| Protein Family | Slo potassium channel family (BK/MaxK) |
|---|
| Aliases | BK Channel, Slo1, KCa1.1, MaxiK |
|---|
KCNMA1 encodes the alpha subunit of the large-conductance calcium-activated potassium channel (BK channel), also known as Slo1 or MaxiK. BK channels are unique among potassium channels in their dual activation by voltage and intracellular calcium, making them critical regulators of cellular excitability in neurons, smooth muscle cells, and many other cell types.
BK channels have a distinctive architecture:
- Seven Transmembrane Domains: S0-S6, with S1-S4 forming the voltage sensor
- Cytoplasmic Tail: Large cytoplasmic domain (S7-S10) containing calcium-binding sites (RCK domains)
- Tetrameric Assembly: Four alpha subunits form a functional channel
- Splice Variants: Multiple isoforms with distinct properties
| Feature |
Details |
| Conductance |
~250-300 pS (largest K⁺ channel) |
| Calcium Binding |
Two RCK domains per subunit |
| Regulation |
Voltage + Ca²⁺, phosphorylation, hormones |
BK channels serve diverse physiological functions:
- Neuronal Excitability: Repolarizes action potentials, controls firing pattern
- Neurotransmitter Release: Modulates Ca²⁺ influx at presynaptic terminals
- Smooth Muscle Tone: Hyperpolarizes cells, reducing contraction
- Auditory Function: Critical for inner ear hair cell repolarization
- Hormone Secretion: Modulates Ca²⁺ entry in endocrine cells
-
Alzheimer's Disease:
- BK channel dysfunction affects neuronal Ca²⁺ handling
- Altered channel expression in AD brain
- May contribute to synaptic dysfunction
-
Parkinson's Disease:
- May affect dopaminergic neuron survival
- Altered excitability in PD models
-
Epilepsy:
- Some variants alter seizure threshold
- Neuronal BK channel dysfunction contributes to hyperexcitability
- Dystonia: Associated with certain KCNMA1 variants
- Hypertension: Vascular BK channel dysfunction
- Arrhythmias: Cardiac BK channel role in repolarization
BK channels are drug targets for multiple conditions:
| Condition |
Drug |
Status |
Notes |
| Stroke |
BMS-191011 |
Research |
Neuroprotective |
| Hypertension |
Various |
Research |
Vasodilators |
| Urinary Incontinence |
Various |
Research |
Bladder relaxants |
| Epilepsy |
Various |
Research |
Anticonvulsant potential |
- Marty A et al. (1984). Large conductance Ca²⁺-activated K⁺ channels. Nature 309(5966): 354-356. PMID:6325494
- Sah P, Davies P (2000). Calcium-activated potassium channels in neuronal excitability. Annu Rev Physiol 62: 107-129. PMID:10645072
The study of Kcnma1 Protein (Bk Channel) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
BK channels exhibit unique gating properties:
Voltage-Dependent Activation
- The S1-S4 transmembrane domains form the voltage sensor
- Depolarization causes movement of the voltage sensor domain
- This conformational change opens the channel pore
Calcium-Dependent Activation
- Two RCK (Regulator of K+ Conductance) domains in the cytoplasmic tail
- Bind calcium with micromolar affinity
- Calcium binding induces conformational change promoting opening
Slo1 Splice Variants
- Multiple splice variants with different properties
- Stress-regulated splicing
- Tissue-specific expression patterns
¶ Ion Selectivity and Conductance
- Highly selective for potassium ions (PK/PNa > 100)
- Single channel conductance of ~250-300 pS
- One of the largest conductance ion channels known
- Fast activation and deactivation kinetics
BK channels in Alzheimer's disease show several alterations:
- Expression Changes: Altered KCNMA1 expression in AD brain tissue
- Calcium Dysregulation: Impaired calcium sensing affects channel function
- Synaptic Dysfunction: BK channel alterations contribute to synaptic hyperexcitability
- Therapeutic Potential: BK channel modulators may protect against amyloid toxicity
- Dopaminergic neurons show altered BK channel activity
- Channel dysfunction may contribute to neuronal death
- Potential for neuroprotective strategies
Channel Openers
- BMS-191011: Neuroprotective in stroke models
- NS-1619: Investigated for neuroprotection
- Natural compounds: Flavonoids, terpenoids
Channel Blockers
- Paxilline: Research tool, potential anticonvulsant
- IbTX: Scorpion toxin, research use
- KCNMA1-linked Ataxia: Associated with movement disorders
- Developmental Delays: Some variants cause neurological symptoms
- Seizure Disorders: Altered excitability from channel dysfunction
- BK channel activity as a therapeutic target
- Splice variant analysis for diagnosis
- Channel modulator response prediction
- Patch clamp recordings (inside-out, outside-out, cell-attached)
- Single-channel analysis
- Noise analysis
- Site-directed mutagenesis
- Splice variant analysis
- Protein expression studies
- Calcium imaging in neurons
- Fluorescent voltage sensors
- FRET-based channel activity assays